Association Between IVUS Findings and Adverse Outcomes in Coronary Artery Disease (VIVA Study)
Patrick A Calvert, Daniel R Obaid, Martin R Bennett · Prospective cohort study
BlueRipple Assessment
The dream of “vulnerable plaque” imaging is to spot the specific lesions destined to rupture before they cause a heart attack. The VIVA study tested whether intravascular ultrasound with virtual histology could do that.
Using VH-IVUS to image coronary arteries in 170 patients, the investigators identified features that were significantly associated with later major adverse cardiac events: thin-capped fibroatheromas (the classic rupture-prone plaque), a heavy plaque burden exceeding 70 percent, and a small minimum luminal area. Plaques and patients carrying these features were at measurably higher risk.
The finding is encouraging in principle but limited in practice. The associations were statistically significant yet modest in their ability to pinpoint which individual plaque would cause trouble, and the imaging is invasive. It advanced the science of plaque characterization without delivering a tool ready to redirect routine care.
We rate the evidence moderate-to-strong. As a prospective study with adjudicated outcomes it is solid, but its small size and surrogate-heavy approach keep “vulnerable plaque” detection a research pursuit more than a clinical practice.
The original source
Calvert PA, Obaid DR, O'Sullivan M, Shapiro LM, McNab D, Densem CG, et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) study. JACC Cardiovasc Imaging. 2011;4(8):894-901.
BlueRipple Health provides consumer education and research synthesis for informed health advocacy. This is not medical advice. Discuss all health decisions with a qualified clinician.